ADC Therapeutics S.A. (ADCT) Earnings History
Annual and quarterly earnings data from 2017 to 2025
Loading earnings history...
ADCT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ADCT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 90.6% | -133.2% | -175.3% |
| 2024 | 91.6% | -184.4% | -222.8% |
| 2023 | 96.4% | -238.6% | -345.1% |
| 2022 | 98.4% | -58.8% | -74.9% |
| 2021 | 95.9% | -771.6% | -678.2% |
Download Data
Export ADCT earnings history in CSV or JSON format
Free sign-in required to download data
ADC Therapeutics S.A. (ADCT) Earnings Overview
As of May 8, 2026, ADC Therapeutics S.A. (ADCT) reported trailing twelve-month net income of -$137M, reflecting +30.9% year-over-year growth. The company earned $-0.89 per diluted share over the past four quarters, with a net profit margin of -175.3%.
Looking at the long-term picture, ADCT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$90M in fiscal 2017.
ADC Therapeutics S.A. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RCUS (-$369M net income, -142.9% margin), MGNX (-$75M net income, -49.9% margin), ABBV ($4.23B net income, 6.9% margin), ADCT has room to improve margins relative to the peer group. Compare ADCT vs RCUS →
ADCT Earnings vs Peers
Earnings metrics vs comparable public companies
ADCT Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$143M | +9.6% | -$108M | $-1.12 | -175.3% | -133.2% |
| 2024 | -$158M | +34.2% | -$131M | $-1.62 | -222.8% | -184.4% |
| 2023 | -$240M | -52.8% | -$166M | $-2.94 | -345.1% | -238.6% |
| 2022 | -$157M | +31.7% | -$123M | $-1.99 | -74.9% | -58.8% |
| 2021 | -$230M | +6.6% | -$262M | $-3.00 | -678.2% | -771.6% |
| 2020 | -$246M | -111.4% | -$219M | $-3.77 | - | - |
| 2019 | -$116M | +5.4% | -$119M | $-1.74 | -4977.9% | -5102.5% |
| 2018 | -$123M | -37.0% | -$126M | $-2.29 | -10797.9% | -11047.5% |
| 2017 | -$90M | - | -$92M | $-1.53 | -4984.0% | -5084.3% |
See ADCT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADCT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ADCT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonADCT — Frequently Asked Questions
Quick answers to the most common questions about buying ADCT stock.
Is ADCT growing earnings?
ADCT EPS is $-0.89, with earnings growth accelerating to +30.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-137M.
What are ADCT's profit margins?
ADC Therapeutics S.A. net margin is -175.3%, with operating margin at -133.2%. Below-average margins reflect competitive or cost pressures.
How consistent are ADCT's earnings?
ADCT earnings data spans 2017-2025. The accelerating earnings trend is +30.9% YoY. Historical data enables comparison across business cycles.